---
title: "Arcadia Biosciences Announces 2025 Annual Meeting Date"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/262680298.md"
description: "Arcadia Biosciences (RKDA) has announced its 2025 annual meeting of stockholders will take place on December 19, 2025, with updated deadlines for proposals and nominations. This follows a Securities Exchange Agreement with Roosevelt Resources, LP. The latest analyst rating for RKDA is a Hold with a $4.00 price target, while Spark's AI Analyst rates it as Neutral, citing financial challenges and mixed technical signals. The current market cap is $5.32M, and average trading volume is 519,204."
datetime: "2025-10-24T19:27:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262680298.md)
  - [en](https://longbridge.com/en/news/262680298.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262680298.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/262680298.md) | [繁體中文](https://longbridge.com/zh-HK/news/262680298.md)


# Arcadia Biosciences Announces 2025 Annual Meeting Date

The latest update is out from Arcadia Biosciences ( (RKDA) ).

Arcadia Biosciences, Inc. has announced that its 2025 annual meeting of stockholders will be held on December 19, 2025. The company has also informed stockholders of a change in the meeting date and updated deadlines for submitting proposals and nominations for the meeting. This announcement follows a Securities Exchange Agreement with Roosevelt Resources, LP, which involves an all-stock transaction for the combination of the two companies. The meeting and the proxy statement are separate from the special meeting related to this transaction.

The most recent analyst rating on (RKDA) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Arcadia Biosciences stock, see the RKDA Stock Forecast page.

**Spark’s Take on RKDA Stock**

According to Spark, TipRanks’ AI Analyst, RKDA is a Neutral.

Arcadia Biosciences faces significant financial and valuation challenges, with unprofitability and negative cash flow being major concerns. Technical analysis provides some mixed signals, but overall, the stock lacks strong positive indicators. The absence of earnings call data and corporate events further limits the assessment.

To see Spark’s full report on RKDA stock, click here.

**More about Arcadia Biosciences**

**Average Trading Volume:** 519,204

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $5.32M

For a thorough assessment of RKDA stock, go to TipRanks’ Stock Analysis page.

### 相关股票

- [Arcadia Biosciences (RKDA.US)](https://longbridge.com/zh-CN/quote/RKDA.US.md)

## 相关资讯与研究

- [Arcadis Bags Two Project Wins Worth Over $18 Bln In Los Angeles](https://longbridge.com/zh-CN/news/278585148.md)
- [Arcadis gewinnt Zuschlag für Sportpark- und Kläranlagenprojekte in Macau](https://longbridge.com/zh-CN/news/275268306.md)
- [Arcadia Biosciences Raises $2.1 Million Through Exercise of Preferred Investment Options](https://longbridge.com/zh-CN/news/272540569.md)